Back to Lab Members

Elke Kurz
B.A. Heidelberg, Germany
elke.kurz@med.nyu.edu

Publications
 
FK506 prevents stroke-induced generation of ceramide and apoptosis signaling.
Herr I, Martin-Villalba A, Kurz E, Roncaioli P, Schenkel J, Cifone MG, Debatin KM.
Brain Res. 1999 May 1;826(2):210-9.
 
CD95 (APO-1/Fas) mutations in childhood T-lineage acute lymphoblastic leukemia.
Beltinger C, Kurz E, Böhler T, Schrappe M, Ludwig WD, Debatin KM.
Blood. 1998 May 15;91(10):3943-51.
 
Modeling of C/EBPalpha mutant acute myeloid leukemia reveals a common expression signature of committed myeloid leukemia-initiating cells. Kirstetter P, Schuster MB, Bereshchenko O, Moore S, Dvinge H, Kurz E, Theilgaard-Mönch K, Månsson R, Pedersen TA, Pabst T, Schrock E, Porse BT, Jacobsen SE, Bertone P, Tenen DG, Nerlov C.
Cancer Cell. 2008 Apr;13(4):299-310.
 
Distinct C/EBPalpha motifs regulate lipogenic and gluconeogenic gene expression in vivo.
Pedersen TA, Bereshchenko O, Garcia-Silva S, Ermakova O, Kurz E, Mandrup S, Porse BT, Nerlov C. EMBO J. 2007 Feb 21;26(4):1081-93. Epub 2007 Feb 8.
     
The proline-histidine-rich CDK2/CDK4 interaction region of C/EBPalpha is dispensable for C/EBPalpha-mediated growth regulation in vivo. Porse BT, Pedersen TA, Hasemann MS, Schuster MB, Kirstetter P, Luedde T, Damgaard I, Kurz E, Schjerling CK, Nerlov C.
Mol Cell Biol. 2006 Feb;26(3):1028-37.